Loading…
Loading…
Boston Scientific Corp
NYSE · Stock Profile · Market Cap $105.67B
Current Price
$71.28
+0.11%GoodMoat Value
$63.65
10.7% overvaluedFree cash flow has been growing at 33.1% annually.
Forward estimates use 33.1% FCF growth (CAGR)
Net Debt: 9.5B
4.1B
FY24
4.2B
FY24
16.7B
FY24
4.7B
FY25
5.1B
FY25
5.1B
FY25
20.1B
FY25
324M
FY24
468M
FY24
1.9B
FY24
674M
FY25
797M
FY25
755M
FY25
2.9B
FY25
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Country
Massachusetts, USA
Free cash flow has been growing at 33.1% annually.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →This stock does not currently pay a dividend.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.
Sector
Healthcare
Industry
Medical Devices
Exchange
NYSE
Country
Massachusetts, USA